Scroll Top
Gain Therapeutics Inc.

Gain Therapeutics Shares Promising Phase 1 Data on GT-02287

Investor’s Hangout

February 18, 2026

Gain Therapeutics Shares Promising Phase 1 Data on GT-02287

Latest Articles

Clear Filters
January 26, 2026
5 Investigational Therapies That Could Change the Parkinson’s Landscape
https://www.biospace.com/drug-development/5-investigational-therapies-that-could-change-the-parkinsons-landscape
Read More
January 13, 2026
Early trial data suggest GT-02287 may aid Parkinson’s symptoms
https://parkinsonsnewstoday.com/news/early-trial-data-suggest-gt-02287-aid-parkinsons-symptoms/
Read More
January 9, 2026
New data suggest enzyme modulator may slow Parkinson’s
https://longevity.technology/news/new-data-suggest-enzyme-modulator-may-slow-parkinsons/
Read More